8:00-8:30 |
Registration and Coffee |
8:30-9:15 |
State of the Neurotechnology Industry: 2025
James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto provides his insights and observations on the state of the neurotechnology industry. He surveys changes in the competitive landscape that have occurred over the years, the most significant events of the last year, and challenges confronting the industry in years ahead. |
9:15-10:00 |
Keynote Address
J. Thomas Mortimer, Ph.D., Emeritus Professor of Biomedical Engineering, Case Western Reserve University
Why Devices Need Doctors |
10:00-10:30 |
Refreshment Break |
10:30-11:15 |
Navigating the Valley of Death: Building a Sustainable Neuromodulation Business
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Mir Imran, Managing Partner, InCube Ventures
Jeremy Koff and his panelsits review key elements of launching a commercial neurotech firm, such as financial modeling, establishing valuations, selecting suppliers, and managing competition. |
11:15-12:00 |
Changing the Mix: Private Investors Pick Up the Slack in Neurotech Funding
James Cavuoto, Editor, Neurotech Reports, Moderator
Lu Zhang, Founder and Managing Partner, Fusion Fund
Although federal funding for new neurotech vendors has taken a hit in 2025, a host of private firms have pitched in to fill the pipeline. In this session, a panel of investment professionals will offer their insight on the state of neurotech funding. |
12:00-1:30 |
Luncheon, Sponsored by Cirtec Medical |
1:30-3:00 |
Neurotechnology Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Tetiana Aleksandrova, Founder and CEO, Subsense Inc.
Daniel Powell, CEO, OhmBody
Miri Polacheck, Co-founder, BrainValue Neurotech
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
From Brainwaves to Breakthroughs: The AI-Driven BCI Revolution
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Oliver Armitage, Ph.D., Vice President of Neural Data, Axoft
Ryan Field, Ph.D., CEO, Kernel
Andreas Forsland, CEO, Cognixion
This session explores the powerful convergence of BCIs and AI, highlighting how advances in decoding, machine learning, and adaptive algorithms are revolutionizing the way we interact with and understand the brain. Leaders in the field will discuss breakthroughs in speech and movement restoration, neuroadaptive systems, and closed-loop therapeutics, while also addressing the challenges of clinical translation, ethical deployment, and real-world integration.
|
4:15-5:00 |
New Realities at HHS: Navigating Regulatory and Reimbursement Changes
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Kristen Mittal, CEO, Mittal Consulting
In this session, we'll explore the impact of new leadership at the FDA, CMS, CDC, and other agencies and examine the outlook for future regulatory and reimbursement trends.
|
5:00-7:00 |
Cocktail Reception, Sponsored by MST
|
|
|
8:00:8:30 |
Registration and Coffee |
8:30-9:15 |
Keynote Address
Edward Chang, M.D., Professor and Chair of Neurological Surgery, University of California, San Francisco
|
9:15-10:00 |
Choosing Your Pain: Neuromodulation Firms Exploit a Variety of Therapies
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Vendors of peripheral nerve stimulation systems have begun to impact the market for spinal cord stimulation. Meanwhile new therapeutic approaches such as sensory stimulation, magnetic stim, and focused ultrasound are coming to market. In this session, we'll examine the competitive landscape among the established players and upstarts.
|
10:00-10:30 |
Coffee Break
|
10:30-11:15 |
A Body of Work: Neuromodulation Firms Move Beyond the CNS
Victor Pikov, Contributing Editor, Neurotech Reports, Moderator
Neuromodulation firms have expanded their anatomical targets to look at treating non-neurological disorders such as OSA, OAB, and inflammation. In this session we'll look at some of the new competitive battlegrounds in neuromodulation and bioelectronic medicine. |
11:15-12:00 |
Skin Deep: Wearables Vendors Build New Markets and Applications
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
David Groves, Business Director, BrainsConnected
While the neurotech industry to date has been largely driven by implantable devices, a new class of vendors has emerged to offer noninvasive neuromodulation and neurosensing applications. In this session, we'll examine the market potential for consumer neurotech and digital health. |
12:00-1:30 |
Luncheon, Sponsored by Cirtec Medical
Presentation of 2025 Gold Electrode Awards |
1:30-3:00 |
Neurotechnology Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Boris Goldstein, Ph.D., CEO, BrainBit
Emile Radyte, CEO, Samphire Neuroscience
Katya Sverdlov, CEO and Co-Founder, JelikaLite
Fred Walke, CEO, Wave Neuroscience
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
It Takes a Village: Neurotech Industry Looks to Outside Help
James Cavuoto, Editor, Neurotech Reports, Moderator
Vojkan Mihajlovic, Ph.D., Principal Scientist, imec
The overall health of the neurotechnology industry depends on the availability of a network of third-party suppliers, including manufacturing firms, consultants, nonprofit organizations, and funding sources. In this session, we'll hear from some of the parties who help keep the industry moving forward. |
4:15-5:00 |
Fireside Chat: Neurotech's Past and Future
James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Paul Grand, CEO, MedTech Innovator
In this wrap-up session, Neurotech Reports editor James Cavuoto sits down with an iconic industry veteran to review the neurotech industry's trajectory from emerging market to established medtech sector over the last 25 years.
|
5:00-7:00 |
Cocktail Reception, Sponsored by MST |
|
|